Advertisement

Cloning-Independent Expression and Screening of Enzymes Using Cell-Free Protein Synthesis Systems

Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 1118)

Abstract

We present a strategy for expression and screening of microbial enzymes without involving cloning procedures. Libraries of putative ω-transaminases (ω-TA) and mutated Candida antarctica lipase B (CalB) are PCR-amplified from bacterial colonies and directly expressed in an Escherichia coli-based cell-free protein synthesis system. The open nature of cell-free protein synthesis system also allows streamlined analysis of the enzymatic activity of the expressed enzymes, which greatly shortens the time required for enzyme screening.

We expect that the proposed strategy will provide a universal platform for bridging the information gap between nucleotide sequence and protein function, in order to accelerate the discovery of novel enzymes. The proposed strategy can also serve as a viable option for the rapid and precise tuning of enzyme molecules, not only for analytical purposes, but also for industrial applications. This is accomplished via large-scale production using microbial cells transformed with variant genes selected from the cell-free expression screening.

Key words

Enzyme engineering Combinatorial mutagenesis Cell-free protein synthesis Hot spots 

References

  1. 1.
    Mardis ER (2008) The impact of next-generation sequencing technology on genetics. Trends Genet 24:133–141PubMedCrossRefGoogle Scholar
  2. 2.
    Gorbalenya AE, Koonin EV, Lai MM (1991) Putative papain-related thiol proteases of positive-strand RNA viruses. Identification of rubi- and aphthovirus proteases and delineation of a novel conserved domain associated with proteases of rubi-, alpha- and coronaviruses. FEBS Lett 288:201–205PubMedCrossRefGoogle Scholar
  3. 3.
    Schmidt AJ, Ryjenkov DA, Gomelsky M (2005) The ubiquitous protein domain EAL is a cyclic diguanylate-specific phosphodiesterase: enzymatically active and inactive EAL domains. J Bacteriol 187:4774–4781PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Entzeroth M (2003) Emerging trends in high-throughput screening. Curr Opin Pharmacol 3:522–529PubMedCrossRefGoogle Scholar
  5. 5.
    Goddard JP, Reymond JL (2004) Recent advances in enzyme assays. Trends Biotechnol 22:363–370PubMedCrossRefGoogle Scholar
  6. 6.
    Hertzberg RP, Pope AJ (2000) High-throughput screening: new technology for the 21st century. Curr Opin Chem Biol 4:445–451PubMedCrossRefGoogle Scholar
  7. 7.
    Pereira DA, Williams JA (2007) Origin and evolution of high throughput screening. Br J Pharmacol 152:53–61PubMedCentralPubMedCrossRefGoogle Scholar
  8. 8.
    Turner NJ (2003) Directed evolution of enzymes for applied biocatalysis. Trends Biotechnol 21:474–478PubMedCrossRefGoogle Scholar
  9. 9.
    Wahler D, Reymond JL (2001) High-throughput screening for biocatalysts. Curr Opin Biotechnol 12:535–544PubMedCrossRefGoogle Scholar
  10. 10.
    Hibbert EG, Dalby PA (2005) Directed evolution strategies for improved enzymatic performance. Microb Cell Fact 4:29PubMedCentralPubMedCrossRefGoogle Scholar
  11. 11.
    Ottosson J, Rotticci-Mulder JC, Rotticci D et al (2001) Rational design of enantioselective enzymes requires considerations of entropy. Protein Sci 10:1769–1774PubMedCentralPubMedCrossRefGoogle Scholar
  12. 12.
    Jewett MC, Calhoun KA, Voloshin A et al (2008) An integrated cell-free metabolic platform for protein production and synthetic biology. Mol Syst Biol 4:220PubMedCentralPubMedCrossRefGoogle Scholar
  13. 13.
    Katzen F, Chang G, Kudlicki W (2005) The past, present and future of cell-free protein synthesis. Trends Biotechnol 23: 150–156PubMedCrossRefGoogle Scholar
  14. 14.
    Murthy TV, Wu W, Qiu QQ et al (2004) Bacterial cell-free system for high-throughput protein expression and a comparative analysis of Escherichia coli cell-free and whole cell expression systems. Protein Expr Purif 36: 217–225PubMedCrossRefGoogle Scholar
  15. 15.
    Sawasaki T, Ogasawara T, Morishita R et al (2002) A cell-free protein synthesis system for high-throughput proteomics. Proc Natl Acad Sci U S A 99:14652–14657PubMedCentralPubMedCrossRefGoogle Scholar
  16. 16.
    Shimizu Y, Kuruma Y, Ying BW et al (2006) Cell-free translation systems for protein engineering. FEBS J 273:4133–4140PubMedCrossRefGoogle Scholar
  17. 17.
    Spirin AS (2004) High-throughput cell-free systems for synthesis of functionally active proteins. Trends Biotechnol 22:538–545PubMedCrossRefGoogle Scholar
  18. 18.
    Park CG, Kim TW, Oh IS et al (2009) Expression of functional Candida antarctica lipase B in a cell-free protein synthesis system derived from Escherichia coli. Biotechnol Prog 25:589–593PubMedCrossRefGoogle Scholar
  19. 19.
    Crowley LV (1967) The Reitman-Frankel colorimetric transaminase procedure in suspected myocardial infarction. Clin Chem 13: 482–487PubMedGoogle Scholar
  20. 20.
    Reitman S, Frankel S (1957) A colorimetric method for the determination of serum glutamic oxaloacetic and glutamic pyruvic transaminases. Am J Clin Pathol 28:56–63PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2014

Authors and Affiliations

  1. 1.Department of Fine Chemical Engineering and Applied ChemistryChungnam National UniversityDaejeonSouth Korea
  2. 2.Korea Research Institute of Chemical TechnologyDaejeonSouth Korea

Personalised recommendations